Advisor Group’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | $51K | Sell |
850
-421
| -33% | -$25.3K | ﹤0.01% | 3392 |
|
|
2019
Q3 | $47K | Hold |
1,271
| – | – | ﹤0.01% | 3435 |
|
|
2019
Q2 | $59K | Buy |
1,271
+112
| +10% | +$5.2K | ﹤0.01% | 3236 |
|
|
2019
Q1 | $47K | Buy |
1,159
+212
| +22% | +$8.6K | ﹤0.01% | 3427 |
|
|
2018
Q4 | $44K | Buy |
947
+291
| +44% | +$13.5K | ﹤0.01% | 3260 |
|
|
2018
Q3 | $29K | Buy |
656
+593
| +941% | +$26.2K | ﹤0.01% | 3645 |
|
|
2018
Q2 | $2K | Sell |
63
-912
| -94% | -$29K | ﹤0.01% | 4654 |
|
|
2018
Q1 | $70K | Buy |
975
+654
| +204% | +$47K | ﹤0.01% | 2822 |
|
|
2017
Q4 | $21K | Hold |
321
| – | – | ﹤0.01% | 3688 |
|
|
2017
Q3 | $17K | Buy |
321
+286
| +817% | +$15.1K | ﹤0.01% | 3640 |
|
|
2017
Q2 | $2K | Buy |
+35
| New | +$2K | ﹤0.01% | 4497 |
|
|
2017
Q1 | – | Sell |
-200
| Closed | -$3K | – | 4705 |
|
|
2016
Q4 | $3K | Sell |
200
-14,237
| -99% | -$214K | ﹤0.01% | 4098 |
|
|
2016
Q3 | $200K | Buy |
14,437
+85
| +0.6% | +$1.18K | ﹤0.01% | 1522 |
|
|
2016
Q2 | $140K | Buy |
+14,352
| New | +$140K | ﹤0.01% | 1695 |
|